Detection of Low-Level K65R Variants in Nucleoside Reverse Transcriptase Inhibitor—Naive Chronic and Acute HIV-1 Subtype C Infections

To substantiate reports of greater emergence of the K65R nucleoside reverse transcriptase inhibitor (NRTI) mutation in human immunodeficiency virus type 1 (HIV-1) subtype C, we examined natural low-level K65R expression in subtype C, relative to subtypes B and AE. We used allele-Specific polymerase...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 203; no. 6; pp. 798 - 802
Main Authors Li, Jin-fen, Lipscomb, Jonathan T., Wei, Xierong, Martinson, Neil A., Morris, Lynn, Heneine, Walid, Johnson, Jeffrey A.
Format Journal Article
LanguageEnglish
Published Oxford Oxford University Press 15.03.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To substantiate reports of greater emergence of the K65R nucleoside reverse transcriptase inhibitor (NRTI) mutation in human immunodeficiency virus type 1 (HIV-1) subtype C, we examined natural low-level K65R expression in subtype C, relative to subtypes B and AE. We used allele-Specific polymerase chain reaction to screen HIV-1 amplified by reverse-transcription high-fidelity polymerase chain reaction from subtype C-infected South African women and infants and CRF01 (subtype AE) from Thailand; all subjects were NRTI naive. We found low-level K65R of unknown clinical significance in NRTI-naive subtype C-infected women and infants at frequencies above the natural occurrence in subtypes and AE. The frequent appearance of subtype frameshift deletions at codon 65 supports a propensity for transcription error in this region.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Presented in part: Conference on Retroviruses and Opportunistic Infections in San Francisco, California, 16-19 February, 2010.
Potential conflicts of interest: J.A.J. and W.H. are authors on a patent application for the real-time polymerase chain reaction assays. All other authors report no conflicts of interest.
Disclaimer: The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the official view of the Centers for Disease Control and Prevention (CDC). The use of trade names is for information purposes only and does not constitute CDC endorsement.
ISSN:0022-1899
1537-6613
0022-1899
1537-6613
DOI:10.1093/infdis/jiq126